0.9(top 50%)
impact factor
1.7K(top 10%)
papers
14.4K(top 20%)
citations
52(top 10%)
h-index
0.9(top 50%)
impact factor
2.1K
all documents
15.4K
doc citations
81(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Genetics of adult gliomaCancer Genetics2012737
2Promiscuous partnerships in Ewing's sarcomaCancer Genetics2011213
3The prognostic significance of cytogenetics and molecular profiling in multiple myelomaCancer Genetics2011178
4Pheochromocytoma and paraganglioma: understanding the complexities of the genetic backgroundCancer Genetics2012177
5miR-27 promotes human gastric cancer cell metastasis by inducing epithelial-to-mesenchymal transitionCancer Genetics2011158
6Regulatory mechanisms of long noncoding RNAs on gene expression in cancersCancer Genetics2017157
7The genetics of dyskeratosis congenitaCancer Genetics2011131
8Detection of structural DNA variation from next generation sequencing data: a review of informatic approachesCancer Genetics2013131
9Analysis of miRNA-gene expression-genomic profiles reveals complex mechanisms of microRNA deregulation in osteosarcomaCancer Genetics2011126
10The cancer COMPASS: navigating the functions of MLL complexes in cancerCancer Genetics2015122
11Mechanisms by which SMARCB1 loss drives rhabdoid tumor growthCancer Genetics2014119
12Multiple endocrine neoplasia type 1 (MEN1): An update of 208 new germline variants reported in the last nine yearsCancer Genetics2016118
13Translocation t(7;19)(q22;q13)—a recurrent chromosome aberration in pseudomyogenic hemangioendothelioma?Cancer Genetics2011113
14Molecular inversion probes: a novel microarray technology and its application in cancer researchCancer Genetics2012103
15Emergence of clonal hematopoiesis in the majority of patients with acquired aplastic anemiaCancer Genetics2015102
16Understanding the limitations of next generation sequencing informatics, an approach to clinical pipeline validation using artificial data setsCancer Genetics201399
17Clinical application of amplicon-based next-generation sequencing in cancerCancer Genetics201398
18Evaluation of commercial kits for purification of circulating free DNACancer Genetics201890
19Monoclonality of multifocal epithelioid hemangioendothelioma of the liver by analysis of WWTR1-CAMTA1 breakpointsCancer Genetics201286
20MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cellsCancer Genetics201285
21Exon scanning by reverse transcriptase–polymerase chain reaction for detection of known and novel EML4–ALK fusion variants in non–small cell lung cancerCancer Genetics201184
22Inhibition of the mevalonate pathway affects epigenetic regulation in cancer cellsCancer Genetics201584
23Bone morphogenetic protein 4—a fascinating regulator of cancer cell behaviorCancer Genetics201281
24Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesotheliomaCancer Genetics201381
25Pathology and diagnosis of SMARCB1-deficient tumorsCancer Genetics201481
26Clinical genomics of renal epithelial tumorsCancer Genetics201180
27Molecular pathology and its diagnostic use in bone tumorsCancer Genetics201280
28Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesisCancer Genetics201179
29Distinct germ line polymorphisms underlie glioma morphologic heterogeneityCancer Genetics201177
305-hydroxymethylcytosine in cancer: significance in diagnosis and therapyCancer Genetics201577
31The potential utility of re-mining results of somatic mutation testing: KRAS status in lung adenocarcinomaCancer Genetics201677
32The genetics of gestational trophoblastic disease: a rare complication of pregnancyCancer Genetics201276
33Recurrent copy number alterations in prostate cancer: an in silico meta-analysis of publicly available genomic dataCancer Genetics201476
34MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAFCancer Genetics201274
35FISH-based determination of HER2 status in circulating tumor cells isolated with the microfluidic CEE™ platformCancer Genetics201173
36ARID1A and TERT promoter mutations in dedifferentiated meningiomaCancer Genetics201573
37Evolution in a transmissible cancer: a study of the chromosomal changes in devil facial tumor (DFT) as it spreads through the wild Tasmanian devil populationCancer Genetics201272
38Germline and somatic mutations in meningiomasCancer Genetics201572
39SMARCB1 mutations in schwannomatosis and genotype correlations with rhabdoid tumorsCancer Genetics201471
40Circulating cell-free DNA for non-invasive cancer managementCancer Genetics201871
41A genome-wide approach to comparative oncology: high-resolution oligonucleotide aCGH of canine and human osteosarcoma pinpoints shared microaberrationsCancer Genetics201270
42MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasmCancer Genetics201369
43Increased yield of actionable mutations using multi-gene panels to assess hereditary cancer susceptibility in an ethnically diverse clinical cohortCancer Genetics201668
44Clinical testing with a panel of 25 genes associated with increased cancer risk results in a significant increase in clinically significant findings across a broad range of cancer historiesCancer Genetics201768
45The role of the histone demethylase KDM4A in cancerCancer Genetics201566
46SVAtools for junction detection of genome-wide chromosomal rearrangements by mate-pair sequencing (MPseq)Cancer Genetics201865
47Chronic lymphocytic leukemia: a clinical and molecular heterogenous diseaseCancer Genetics201363
48Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell linesCancer Genetics201563
49MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcomaCancer Genetics201260
50Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromesCancer Genetics201159